IQVIA & Veeva Team Up in the U.S. to Transform Life Sciences

IQVIA and Veeva Systems announced a global clinical and commercial collaboration and the complete resolution of all pending legal disputes. The collaboration is for a long-term agreement; customers can utilize software, data, technology, service offerings, etc., from Veeva and IQVIA together in a simple and efficient manner.

How the collaboration between IQVIA and Veeva will benifit:

Commercial: The companies have formed master data with software third-party access (TPA) agreements that allow IQVIA or Veeva data to be used with each other’s software or services in customer instances, including the use of IQVIA data in Veeva Network for master data management (MDM), Veeva Nitro for analytics, and Veeva AI.
Clinical: This partnership will benefit clinical data management, clinical technology solutions, as well as EDC programming expertise with Veeva software to foster database builds, study locks, and data delivery.

IQVIA is a prominent global provider of clinical research services, commercial insights as well as healthcare intelligence to the life sciences and healthcare industries. The company is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry.

Similarly, Veeva is the global provider of cloud software for the life sciences industry. Focused on innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world’s largest biopharmaceutical companies to emerging biotechs.

Executive Statement

According to Ari Bousbib, chairman and CEO of IQVIA, IQVIA and Veeva’s partnerships will bring together best-in-class capabilities in information, AI, technology, along with services for their shared clients. This will also enable IQVIA customers on Veeva platforms to accelerate clinical development, bring treatments to market more efficiently, and improve access to innovations for patients.

Share this story

About the author

Mirza Aamir

is a dynamic writer with over five years of experience in creating compelling and insightful content across a diverse range of industries, including automotive and transportation, energy, consumer electronics, bulk chemical, and food & beverages. With a strong foundation in writing blogs, articles, press releases, preview analysis, and other content formats, he has honed the ability to tailor content to meet the needs of different audiences. His expertise in SEO, combined with an in-depth understanding of market trends, enables him to produce content that is both search-engine optimized and industry-relevant, making him a trusted voice in blog and news writing.

With a passion for research and a keen eye for detail, he ensures that every piece of content is backed by the latest industry data and trends. His ability to breathe life into words allows him to craft engaging and informative content that resonates with readers, while his insights into SEO further elevate the impact of his work. He is committed to staying ahead of the curve in an ever-evolving digital landscape, and he approaches each project with a focus on delivering value to both clients and audiences. Through his work, he continues to contribute to the advancement of content marketing by offering a unique perspective on how content can influence consumer behavior and industry conversations.

See all stories LinkedIn